Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
NCT04798651Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2021
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Functional and phenotypical characterization of the blood and CSF lymphocytes at Day 0. Started Sep 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04798651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04798651.